40330-92-5 Usage
Uses
Used in Pharmaceutical Industry:
(5,6-dihydroxy-1,3-dioxepane-4,7-diyl)dimethanediyl bis(4-methylbenzenesulfonate) (non-preferred name) is used as a potential pharmaceutical compound for its unique structural features that may offer novel therapeutic applications. The presence of hydroxyl and methanediyl groups, along with the bis(4-methylbenzenesulfonate) side chains, could enable interactions with biological targets, making it a candidate for drug development.
Used in Organic Synthesis:
In the field of organic synthesis, (5,6-dihydroxy-1,3-dioxepane-4,7-diyl)dimethanediyl bis(4-methylbenzenesulfonate) (non-preferred name) may serve as a key intermediate or building block for the synthesis of more complex molecules. Its structural components could be utilized in the creation of new compounds with specific properties and applications.
Used in Material Science:
(5,6-dihydroxy-1,3-dioxepane-4,7-diyl)dimethanediyl bis(4-methylbenzenesulfonate) (non-preferred name) could also find applications in material science, where its unique structure might contribute to the development of new materials with specialized properties. These properties could include enhanced stability, reactivity, or specific interactions with other molecules, making it a valuable component in the design of advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 40330-92-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,3,3 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 40330-92:
(7*4)+(6*0)+(5*3)+(4*3)+(3*0)+(2*9)+(1*2)=75
75 % 10 = 5
So 40330-92-5 is a valid CAS Registry Number.
40330-92-5Relevant academic research and scientific papers
Substituted oxygen alicyclic compounds, including methods for synthesis thereof
-
, (2008/06/13)
The invention provides new methods for preparation of cyclic oxygen compounds, including 2,5-disubstituted tetahydrofurans, 2,6-disubstituted tetrahydropyrans, 2,7-disubstituted oxepanes and 2,8-oxocanes. The invention also provides new cyclic oxygen compounds and pharmaceutical compositions and therapeutic methods that comprise such compounds.
Methods for synthesis of substituted tetrahydrofuran compound
-
, (2008/06/13)
The invention includes inter alia new methods for preparation of the pharmaceutically active compound 2-(4-fluorophenoxymethyl)-5-(4-N-hydroxyureidyl-1-butynyl)-tetrahydrofuran and precursors thereof.
Method for the synthesis of pharmacologically active compounds and intermediates for such synthesis
-
, (2008/06/13)
A process for the preparation of an aryloxypropanolamine of the formula wherein Ar is a carbocyclic or heterocyclic aromatic group and R is an alkyl or substituted alkyl group having 1 to 6 carbon atoms, characterized in subjecting a compound of the formula STR1 to oxidative cleavage to a dialdehyde of the formula STR2 which is then made subject to reduction, amination, acetal hydrolysis, and, where required, removal of a nitrogen protective group, to the formation of a compound of formula I, or an acid addition salt thereof, a compound of formula II and the preparation thereof from mannitol.
